Royal college

PRIVATE SECTOR PURSUIT OF A SUSTAINABLE FUTURE: THE GROWTH STORY OF OUR TIME

Retrieved on: 
Thursday, March 14, 2024

LONDON, March 14, 2024 /PRNewswire/ -- Demonstrating the important role the private sector plays in driving a more sustainable economy, the Sustainable Markets Initiative today published its 2023 Impact Report, The Growth Story of Our Time.

Key Points: 
  • https://www.sustainable-markets.org/news/as-strategic-partner-for-cop28-...
    Brian Moynihan, Chair and CEO of Bank of America, and Chair of the Sustainable Markets Initiative said:
    "The private sector has the capital, the talent, and the ingenuity to drive a more sustainable business infrastructure.
  • We accelerated progress through cross-Task Force collaboration, helping Sustainable Markets Initiative CEOs develop solutions and scale not achievable by one industry alone.
  • Jennifer Jordan-Saifi, CEO of the Sustainable Markets Initiative said:
    "The private sector has emerged as the vanguard of the new era – one where profitability and the global public good are not mutually exclusive.
  • Founded by His Majesty King Charles III in 2020, as the Prince of Wales, the Sustainable Markets Initiative has become the world's 'go-to' private sector organisation on transition.

PRIVATE SECTOR PURSUIT OF A SUSTAINABLE FUTURE: THE GROWTH STORY OF OUR TIME

Retrieved on: 
Thursday, March 14, 2024

LONDON, March 14, 2024 /PRNewswire/ -- Demonstrating the important role the private sector plays in driving a more sustainable economy, the Sustainable Markets Initiative today published its 2023 Impact Report, The Growth Story of Our Time.

Key Points: 
  • https://www.sustainable-markets.org/news/as-strategic-partner-for-cop28-...
    Brian Moynihan, Chair and CEO of Bank of America, and Chair of the Sustainable Markets Initiative said:
    "The private sector has the capital, the talent, and the ingenuity to drive a more sustainable business infrastructure.
  • We accelerated progress through cross-Task Force collaboration, helping Sustainable Markets Initiative CEOs develop solutions and scale not achievable by one industry alone.
  • Jennifer Jordan-Saifi, CEO of the Sustainable Markets Initiative said:
    "The private sector has emerged as the vanguard of the new era – one where profitability and the global public good are not mutually exclusive.
  • Founded by His Majesty King Charles III in 2020, as the Prince of Wales, the Sustainable Markets Initiative has become the world's 'go-to' private sector organisation on transition.

The vast majority of GPs resisted the founding of the NHS – here’s why

Retrieved on: 
Friday, April 5, 2024

Securing the reluctant assent of general practitioners (GPs) was one of Labour health minister Nye Bevan’s most difficult tasks in founding the NHS by July 5 1948.

Key Points: 
  • Securing the reluctant assent of general practitioners (GPs) was one of Labour health minister Nye Bevan’s most difficult tasks in founding the NHS by July 5 1948.
  • Bevan’s eventual compromise with the doctors’ union representing GPs, the British Medical Association (BMA), still casts its shadow over health services today.
  • Bevan became minister on August 5 1945, inheriting a legacy of attempts to create a health service during the second world war.
  • These different groups of doctors were the hospital specialists and consultants, local authority medical officers and GPs.

Troublesome

  • While Bevan bought hospital specialists and consultants and sold out the ideals of local authority medical officers, GPs remained troublesome throughout negotiations, right up to the day the NHS began.
  • GPs remained independent doctors who ran their own surgeries, maintaining their own list of patients.
  • Poor pay from the 1911 reforms meant lists were bloated for GPs to remain afloat, especially in deprived areas.
  • Together, these last-minute concessions meant the NHS launched to much fanfare in Park Hospital, Trafford, by Bevan on July 5 1948.

Legacy

  • Despite recurrent rounds of reforms over the intervening decades, GPs remain mostly independent doctors contracted to provide certain services rather than salaried workers.
  • Despite these losses, the basic professional model that GPs fought hard to retain in 1948 – one dating back to 1911 – remains recognisable today.


Michael Lambert has received funding from the Economic and Social Research Council, Wellcome Trust, and National Institute for Health Research.

Treatment.com AI Provides Corporate Update

Retrieved on: 
Thursday, February 29, 2024

VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update. Treatment has been working diligently to continue its acceleration into the US market. A few key milestones the Company has accomplished are as follows:

Key Points: 
  • Treatment Provides Platform to Support Healthcare in Nairobi, Kenya
    VANCOUVER, British Columbia, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update.
  • Dr. Kevin Peterson is the Founder and Chief Medical Officer of Treatment.com AI Inc.
  • Whilst utilizing AI, the GLM has been curated & evaluated by 150+ physicians globally to be correct, reliable and accurate.
  • Treatment’s platform provides clinical decision support to assist the healthcare workers in making an accurate diagnosis.

Corbus Pharmaceuticals Appoints Dr. Dominic Smethurst as Chief Medical Officer

Retrieved on: 
Wednesday, February 28, 2024

NORWOOD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today announced the appointment of Dr. Dominic Smethurst, MA MRCP, as the Company’s Chief Medical Officer (CMO).

Key Points: 
  • NORWOOD, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a precision oncology company with a diversified portfolio, today announced the appointment of Dr. Dominic Smethurst, MA MRCP, as the Company’s Chief Medical Officer (CMO).
  • Additionally, Dr. Smethurst will help guide strategic development of CRB-913, the Company’s highly peripherally restricted CB1 inverse agonist for the treatment of obesity.
  • “We are pleased to welcome Dominic to the Corbus team and look forward to benefitting from his experience in developing novel oncology therapeutics including ones that specifically target Nectin-4", said Yuval Cohen, Ph.D., Chief Executive Officer of Corbus.
  • Previously, Dr. Smethurst worked as a consultant advising biopharma companies, providing guidance on clinical development strategies and licensing projects.

OncoHost Selected to Present in Oral Minisymposium at American Association of Cancer Research (AACR) Annual Meeting 2024

Retrieved on: 
Tuesday, March 5, 2024

BINYAMINA, Israel and CARY, N.C., March 5, 2024 /PRNewswire/ -- OncoHost, a technology company transforming the approach to precision medicine for improved patient outcomes, today announced it will be presenting new results at the American Association for Cancer Research (AACR) Annual Meeting taking place in San Diego, California from April 5-10, 2024. The oral presentation will feature insights from the company's PROPHETIC trial, to be delivered by Prof. Jarushka Naidoo, consultant medical oncologist at Beaumont Hospital Dublin, professor at the Royal College of Surgeons in Ireland, and co-author of the abstract.

Key Points: 
  • BINYAMINA, Israel and CARY, N.C., March 5, 2024 /PRNewswire/ -- OncoHost , a technology company transforming the approach to precision medicine for improved patient outcomes, today announced it will be presenting new results at the American Association for Cancer Research (AACR) Annual Meeting taking place in San Diego, California from April 5-10, 2024.
  • Additionally, biological insights related to treatment resistance and immune-related toxicity will be presented.
  • "We are honored to be selected to present our research at the AACR Annual Meeting, highlighting the capabilities of our PROphet® platform in guiding treatment decisions for NSCLC," said Ofer Sharon, MD, CEO of OncoHost.
  • It is a privilege to contribute to this research for the benefit of the cancer community."

Improving the working lives of nurses across Canada

Retrieved on: 
Monday, March 4, 2024

To help support and retain members of the nursing workforce, today, the Honourable Mark Holland, Canada's Minister of Health joined Dr. Leigh Chapman, Canada's Chief Nursing Officer at Trillium Health Partners, Credit Valley Hospital, to announce the release of the Nursing Retention Toolkit: Improving the Working Lives of Nurses in Canada to help improve the working lives of nurses.

Key Points: 
  • To help support and retain members of the nursing workforce, today, the Honourable Mark Holland, Canada's Minister of Health joined Dr. Leigh Chapman, Canada's Chief Nursing Officer at Trillium Health Partners, Credit Valley Hospital, to announce the release of the Nursing Retention Toolkit: Improving the Working Lives of Nurses in Canada to help improve the working lives of nurses.
  • The toolkit will be shared widely throughout Canada's health care system- including with nurses, nursing employers, and health authorities across the country.
  • As a resource created by nurses and for nurses, the toolkit is the result of a collaborative effort with the nursing community which shares the federal government's commitment to improve nursing retention in Canada.
  • Category-based selection allows Canada to issue invitations to apply to prospective permanent residents with specific work experience, including in health care.

Find Therapeutics Announces Appointment of Dr. Anthony Johnson to its Board of Directors

Retrieved on: 
Monday, March 4, 2024

"On behalf of the Board of Directors, I am delighted to welcome Tony to the team," said Philippe Douville, President and CEO of Find Therapeutics.

Key Points: 
  • "On behalf of the Board of Directors, I am delighted to welcome Tony to the team," said Philippe Douville, President and CEO of Find Therapeutics.
  • He currently serves as President and CEO of Domain Therapeutics, Chairman of the Board for Outrun Therapeutics and Board Director for Nanosyrinx.
  • Dr. Johnson was previously President and CEO of Goldfinch Bio and, prior to that, Head of Early Clinical Development.
  • Find Therapeutics also announces that Pascal Neuville, Ph.D., has stepped down from the board as a Non-Executive Director effective March 3, 2024.

Gateways Hospital and Mental Health Center Opens New Sensory Room, Providing Vulnerable Clients with Innovative, Client-Centered Care

Retrieved on: 
Friday, March 1, 2024

LOS ANGELES, March 1, 2024 /PRNewswire/ -- Gateways Hospital and Mental Health Center unveiled its groundbreaking Sensory Room, a pioneering addition to acute patient care in Los Angeles, generously funded by a $45,000 grant from the Robert Ellis Simon Foundation. This innovative space signifies Gateways' commitment to implementing client-centered approaches, blending the latest inpatient psychiatric care practices with immersive sensory interventions, meaningful activities, and fostering connections between clients and caregivers.

Key Points: 
  • Colleen Carroll, Occupational Therapy Director at Gateways Mental Health Center and Hospital, expressed enthusiasm about the sensory room's impact, stating, "Gateways prioritizes resources that prioritize our clients' well-being.
  • Guided by Gateways' mental health professionals, clients can customize their sensory experiences by adjusting lighting, sound, and tactile elements, granting them autonomy over their care.
  • "This grant empowers us to redefine acute mental health care by providing a safe, engaging experience for our clients," said Dr. Wong.
  • "Gateways' Sensory Room sets a new standard for patient-centered care, aligning with our mission to empower individuals in their mental health journey."

Japan House London Announces Design Discoveries: Towards a DESIGN MUSEUM JAPAN

Retrieved on: 
Tuesday, February 20, 2024

LONDON, Feb. 20, 2024 /PRNewswire/ -- Japan is synonymous with exemplary design and yet has no dedicated national museum of design. Leading Japanese designers from different disciplines were asked, "If there were a permanent Japanese design collection, what would you put in it?". Their diverse responses are the subject of an exciting new exhibition opening at Japan House London in the spring, following successful shows at the National Art Center in Tokyo and at partner sites in Los Angeles and São Paulo.

Key Points: 
  • LONDON, Feb. 20, 2024 /PRNewswire/ -- Japan is synonymous with exemplary design and yet has no dedicated national museum of design.
  • Guests are also encouraged to mark sites of interesting design they have encountered across the world on an expansive "Design Map".
  • Sam Thorne, Director General and CEO of Japan House, said:
    "Spanning ten millennia, this exhibition is an experiment in imagining what a design museum of the future might look like.
  • The exhibition was first shown at the National Art Center in Tokyo, followed by Japan House São Paulo in 2023 and Japan House Los Angeles in January 2024.